This common vitamin could help fight one of the deadliest brain cancers
High-dose vitamin B3 is showing intriguing early promise as an addition to standard glioblastoma treatment, with 82% of patients in a small trial remaining progression-free after six months.
Brief by WorldPing · Original reporting by ScienceDaily
WorldPing
